Alpha 1-Antitrypsin Does Not Inhibit Human Monocyte Caspase-1

Abstract

BackgroundAlpha 1-antitrypsin (A1AT) is a 52 kDa serine protease inhibitor produced largely by hepatocytes but also by mononuclear phagocytes. A1AT chiefly inhibits neutrophil elastase and proteinase-3 but has also been reported to have immune modulatory functions including the ability to inhibit caspases. Its clinical availability for infusion suggests that A1AT therapy might modulate caspase related inflammation. Here we tested the ability of A1AT to modulate caspase-1 function in human mononuclear phagocytes.MethodsPurified plasma derived A1AT was added to active caspase-1 in a cell-free system (THP-1 lysates) as well as added exogenously to cell-culture models and human whole blood models of caspase-1 activation. Functional caspase-1 activity was quantified by the cleavage of the caspase-1 specific fluorogenic tetrapeptide substrate (WEHD-afc) and the release of processed IL-18 and IL-1β.ResultsTHP-1 cell lysates generated spontaneous activation of caspase-1 both by WEHD-afc cleavage and the generation of p20 caspase-1. A1AT added to this cell free system was unable to inhibit caspase-1 activity. Release of processed IL-18 by THP-1 cells was also unaffected by the addition of exogenous A1AT prior to stimulation with LPS/ATP, a standard caspase-1 activating signal. Importantly, the A1AT exhibited potent neutrophil elastase inhibitory capacity. Furthermore, A1AT complexed to NE (and hence conformationally modified) also did not affect THP-1 cell caspase-1 activation. Finally, exogenous A1AT did not inhibit the ability of human whole blood samples to process and release IL-1β.ConclusionsA1AT does not inhibit human monocyte caspase-1.

Alpha-1 Antitrypsin Inhibits ATP-Mediated Release of Interleukin-1β via CD36 and Nicotinic Acetylcholine Receptors

“…Exogenous AAT can enter the cytoplasm via lipid rafts ( 33 ) and was suggested to directly inhibit the proteolytic activity of casp-1 ( 34 , 35 ). Although the inhibition of cytoplasmic casp-1 of intact cells by AAT was disputed ( 36 ), we wondered if this mechanism is responsible for the AAT-mediated suppression of IL-1β release. This hypothesis was falsified by two independent experiments.…”

Alpha-1-anti-trypsin-Fc fusion protein ameliorates gouty arthritis by reducing release and extracellular processing of IL-1β and by the induction of endogenous IL-1Ra

“…However, another study indicates that plasma-derived AAT did not reduce caspase-1 activity in the THP-1 macrophage cell line or in cell free extracts, and had no effect on whole human blood production of IL-1β 44. Because IL-1 stimulates caspase-1 gene expression in human blood monocytes45 and caspase-1 cleavage of the IL-18 precursor is IL-1β dependent,46 a reduction in IL-1β will also reduce the level of caspase-1 itself without directly affecting the enzymatic function of caspase-1.…”

α1-Antitrypsin reduces rhinovirus infection in primary human airway epithelial cells exposed to cigarette smoke

“… 32 , 33 The effect of A1AT on caspase-1, a component of inflammasomes, is controversial as some studies demonstrate the inhibitory effect of A1AT on caspase-1 activity, 34 while others did not find any effects. 35 …”